Post Tagged with: "Novartis Pharmaceuticals Corporation"
Novartis enters into an exclusive option agreement with Ionis and Akcea to license two investigational treatments expected to reduce cardiovascular risk in patients living with elevated levels of lipoprotein.
The results of the sickle cell study are being published in The New England Journal of Medicine.
Novartis Acquires Selexys Pharmaceuticals Corporation, SelG1 Antibody for Pain Reduction in Sickle Cell Disease
Acquisition complements and broadens Novartis' hematology pipeline and underscores commitment to improving care for patients with high unmet needs.
Compound offers a potential tool for fighting drug-resistant malaria parasites.
The event will take place November 29 on the Novartis Campus in Basel, Switzerland and will also be webcast.
Meet Novartis' flying hospital that brings training to local eye care professionals in under-resourced communities
Novel Novartis Malaria Compound Shows Potential to be Effective Against Infections Resistant to Antimalarial Drugs
Each year, malaria kills nearly half a million people, most of whom are children.
New Novartis Point of Care Niji System May Provide Earlier Diagnosis of Severe Allergic Asthma, Faster Treatment Decisions
Point of care in office diagnostics may accelerate treatment decisions that could lead to improved patient care and outcomes
Novartis is using digital technology to enhance the quality, transparency and reach of its interactions with the medical community.
Accenture named Julie Spellman Sweet to head its U.S. operations. As of next month, four of the six major consulting firms will have women leaders.
The companies with the best data for women in management and senior roles use three best practices most frequently – mentoring, employee-resource groups, and flexible workplaces
What is the difference between the Top 10 and the rest of the DiversityInc Top 50? Deep CEO and senior leadership involvement, creating the need for best practices that lead to significant human-capital improvements.
New Jersey City University honors DiversityInc CEO Luke Visconti and others on a night pressing commitment to diversity and service to the community.
An economics professor uses an unusual ratio to describe the lack of gender equity at the top level of management.
The purpose of the initiative at the company’s East Hanover campus was to share insights with special needs young adults about career possibilities and to help build a diverse local future workforce.
Successful medical solutions are personalized, says Novartis Pharmaceuticals Corporation President, Christi Shaw. In a keynote speech, she told DiversityInc’s audience how the drug company is using its knowledge of diverse populations—and its emphasis on an inclusive and innovative workplace—to create the most effective medicines.
Hospitals, health insurers and pharmaceutical companies increasingly rely on employee resource groups to find diverse talent and connect with the communities they serve. Best practices were highlighted by leaders at Novartis Pharmaceuticals Corporation, Mayo Clinic and Blue Cross Blue Shield of Michigan at DiversityInc’s event.
CEOs from Accenture, Wyndham, Sodexo, EY, Novartis, MasterCard and Merck share what makes their companies so special as they accept awards at a DiversityInc event in New York City.
NPC President Christi Shaw told DiversityInc’s audience of the sustained leadership commitment and hard work, especially by Chief Diversity Officer Rhonda Crichlow, that helped the company become No. 1 on The DiversityInc Top 50 Companies for Diversity list.
With 794 people from 302 different companies in attendance, Novartis Pharmaceuticals Corporation was unveiled as the No. 1 company on the 2014 DiversityInc Top 50 list at a special announcement dinner on April 22, 2014, at Cipriani Wall Street in New York City. After ranking in the middle of the pack for a number of …
Novartis Pharmaceuticals Corporation is a case where successful diversity management grew dramatically because of the support and personal involvement of President André Wyss.
Having had great success through cultural transformation, this executive is now taking on a bigger challenge as Division Head of Novartis Pharmaceuticals.
The global background of this Belgium native has allowed him to see firsthand that diversity leads to innovation, engagement and stronger decision making.